Concepts (1143)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Richard A. Larson's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Richard A. Larson has written about over time.
Chromosome AberrationsLeukemia, MyeloidMyelodysplastic SyndromesCytarabinePrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionAntineoplastic Combined Chemotherapy ProtocolsNeoplasms, Second PrimaryLeukemia, Myeloid, AcuteAntineoplastic AgentsPiperazinesLeukemia, Lymphocytic, Chronic, B-CellPyrimidinesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImatinib MesylateFusion Proteins, bcr-ablLeukemia, Myeloid, Chronic-PhaseHematopoietic Stem Cell Transplantationfms-Like Tyrosine Kinase 3Protein Kinase Inhibitors
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Chromosome Aberrations | 55 | 1981 | 2022 | October 1999 |
| Leukemia, Myeloid | 71 | 1981 | 2016 | December 2000 |
| Myelodysplastic Syndromes | 53 | 1986 | 2020 | July 2002 |
| Cytarabine | 77 | 1982 | 2023 | January 2004 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 74 | 1990 | 2024 | July 2006 |
| Remission Induction | 97 | 1987 | 2024 | September 2006 |
| Antineoplastic Combined Chemotherapy Protocols | 137 | 1982 | 2024 | January 2007 |
| Neoplasms, Second Primary | 27 | 1996 | 2022 | April 2008 |
| Leukemia, Myeloid, Acute | 170 | 1983 | 2024 | November 2008 |
| Antineoplastic Agents | 111 | 1984 | 2024 | January 2009 |
| Piperazines | 42 | 2002 | 2015 | March 2009 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 32 | 1992 | 2024 | June 2009 |
| Pyrimidines | 50 | 2002 | 2021 | April 2010 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 67 | 1993 | 2024 | June 2010 |
| Imatinib Mesylate | 51 | 2002 | 2024 | January 2011 |
| Fusion Proteins, bcr-abl | 36 | 1992 | 2024 | April 2011 |
| Leukemia, Myeloid, Chronic-Phase | 18 | 2003 | 2023 | May 2011 |
| Hematopoietic Stem Cell Transplantation | 66 | 1998 | 2023 | May 2012 |
| fms-Like Tyrosine Kinase 3 | 36 | 2001 | 2023 | February 2015 |
| Protein Kinase Inhibitors | 39 | 2004 | 2023 | January 2016 |
To return to the timeline,
click here.